TMT-based proteomic analysis reveals integrins involved in the synergistic infection of reticuloendotheliosis virus and avian leukosis virus subgroup J.

Avian leukosis virus subgroup J Reticuloendotheliosis virus Synergistic infection TMT proteomic analysis

Journal

BMC veterinary research
ISSN: 1746-6148
Titre abrégé: BMC Vet Res
Pays: England
ID NLM: 101249759

Informations de publication

Date de publication:
04 Apr 2022
Historique:
received: 03 11 2021
accepted: 09 03 2022
entrez: 5 4 2022
pubmed: 6 4 2022
medline: 7 4 2022
Statut: epublish

Résumé

Co-infection with the avian leukosis virus subgroup J (ALV-J) and the reticuloendotheliosis virus (REV) increases mutual viral replication, causing a more serious pathogenic effect by accelerating the progression of neoplasia and extending the tumor spectrum. However, the molecular mechanism underlying the synergistic replication of ALV-J and REV remains unclear. Here, we performed this study to compare the differentially expressed proteins among CEF cells infected with ALV-J, REV or both at the optimal synergistic infection time using TMT-based quantitative proteomics. We identified a total of 719 (292 upregulated and 427 downregulated) and 64 (35 upregulated and 29 downregulated) proteins by comparing co-infecting both viruses with monoinfecting ALV-J and REV, respectively. GO annotation and KEGG pathway analysis showed the differentially expressed proteins participated in virus-vector interaction, biological adhesion and immune response pathways in the synergistic actions of ALV-J and REV at the protein levels. Among the differentially expressed proteins, a large number of integrins were inhibited or increased in the co-infection group. Further, eight integrins, including ITGα1, ITGα3, ITGα5, ITGα6, ITGα8, ITGα9, ITGα11 and ITGβ3, were validated in CEF cells by qRT-PCR or western blot. These findings proved that integrins may be key regulators in the mechanism of synergistic infection of REV and ALV-J, which will provide more insight into the pathogenesis of synergism of REV and ALV-J at protein level.

Sections du résumé

BACKGROUND BACKGROUND
Co-infection with the avian leukosis virus subgroup J (ALV-J) and the reticuloendotheliosis virus (REV) increases mutual viral replication, causing a more serious pathogenic effect by accelerating the progression of neoplasia and extending the tumor spectrum. However, the molecular mechanism underlying the synergistic replication of ALV-J and REV remains unclear.
RESULTS RESULTS
Here, we performed this study to compare the differentially expressed proteins among CEF cells infected with ALV-J, REV or both at the optimal synergistic infection time using TMT-based quantitative proteomics. We identified a total of 719 (292 upregulated and 427 downregulated) and 64 (35 upregulated and 29 downregulated) proteins by comparing co-infecting both viruses with monoinfecting ALV-J and REV, respectively. GO annotation and KEGG pathway analysis showed the differentially expressed proteins participated in virus-vector interaction, biological adhesion and immune response pathways in the synergistic actions of ALV-J and REV at the protein levels. Among the differentially expressed proteins, a large number of integrins were inhibited or increased in the co-infection group. Further, eight integrins, including ITGα1, ITGα3, ITGα5, ITGα6, ITGα8, ITGα9, ITGα11 and ITGβ3, were validated in CEF cells by qRT-PCR or western blot.
CONCLUSIONS CONCLUSIONS
These findings proved that integrins may be key regulators in the mechanism of synergistic infection of REV and ALV-J, which will provide more insight into the pathogenesis of synergism of REV and ALV-J at protein level.

Identifiants

pubmed: 35379256
doi: 10.1186/s12917-022-03207-6
pii: 10.1186/s12917-022-03207-6
pmc: PMC8978386
doi:

Substances chimiques

Integrins 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

131

Informations de copyright

© 2022. The Author(s).

Références

Acta Virol. 1999 Apr-Jun;43(2-3):136-42
pubmed: 10696434
Cell Tissue Res. 2001 Sep;305(3):285-98
pubmed: 11572082
Curr Opin Virol. 2018 Oct;32:48-59
pubmed: 30268926
Expert Rev Anti Infect Ther. 2015 Aug;13(8):947-63
pubmed: 26112187
Nat Rev Cancer. 2018 Sep;18(9):533-548
pubmed: 30002479
Nat Rev Mol Cell Biol. 2004 Oct;5(10):816-26
pubmed: 15459662
Carcinogenesis. 2016 Dec;37(12):1117-1128
pubmed: 27664164
Pan Afr Med J. 2018 May 28;30:61
pubmed: 30344845
Cell. 1992 Apr 3;69(1):11-25
pubmed: 1555235
Nucleic Acids Res. 2000 Jan 1;28(1):27-30
pubmed: 10592173
Folia Biol (Praha). 2004;50(5):143-52
pubmed: 15581065
Nat Rev Mol Cell Biol. 2019 Aug;20(8):457-473
pubmed: 31182865
J Virol. 2016 Jul 27;90(16):7303-7312
pubmed: 27252538
J Proteomics. 2020 Aug 15;225:103876
pubmed: 32534212
Avian Pathol. 2015;44(1):43-9
pubmed: 25484188
Front Immunol. 2021 May 04;12:604222
pubmed: 34040601
Biosci Rep. 2017 Apr 10;37(2):
pubmed: 28302677
J Mol Biol. 2018 Aug 17;430(17):2590-2611
pubmed: 29924965
Avian Pathol. 2009 Dec;38(6):443-8
pubmed: 19937533
Nucleic Acids Res. 2019 Jan 8;47(D1):D1211-D1217
pubmed: 30252093
Int J Mol Sci. 2020 Dec 21;21(24):
pubmed: 33371194
Trends Genet. 2000 Sep;16(9):389-95
pubmed: 10973067
Nature. 2015 Nov 19;527(7578):329-35
pubmed: 26524530
J Virol. 1995 Feb;69(2):779-84
pubmed: 7815543
Onco Targets Ther. 2016 Apr 18;9:2317-27
pubmed: 27143927
Retrovirology. 2018 Jul 3;15(1):45
pubmed: 29970099
Virulence. 2020 Dec;11(1):1158-1176
pubmed: 32799626
Virology. 2017 Apr;504:45-51
pubmed: 28152383
Nucleic Acids Res. 2021 Jan 8;49(D1):D545-D551
pubmed: 33125081
Sci Rep. 2019 Feb 26;9(1):2793
pubmed: 30808960
Exp Cell Res. 2019 Jan 1;374(1):85-93
pubmed: 30458180
Nat Rev Cancer. 2002 Feb;2(2):91-100
pubmed: 12635172
Retrovirology. 2017 Dec 2;14(1):55
pubmed: 29197389
Nat Rev Cancer. 2010 Jan;10(1):9-22
pubmed: 20029421
J Gen Virol. 1991 Apr;72 ( Pt 4):801-7
pubmed: 1849967
Curr Opin Virol. 2016 Dec;21:81-86
pubmed: 27580489
Protein Sci. 2019 Nov;28(11):1947-1951
pubmed: 31441146
Cell Immunol. 2011;267(1):56-66
pubmed: 21145045
AIDS Rev. 2007 Jul-Sep;9(3):140-9
pubmed: 17982939
Arch Virol. 2015 Nov;160(11):2669-81
pubmed: 26321473
Med Oncol. 2016 Jul;33(7):75
pubmed: 27287342
Exp Cell Res. 2021 Oct 15;407(2):112815
pubmed: 34496296
Am J Transl Res. 2015 Sep 15;7(9):1564-73
pubmed: 26550456

Auteurs

Xiyao Cui (X)

College of Veterinary Medicine, Shandong Agricultural University, Tai'an, 271018, China.

Xinyue Zhang (X)

College of Veterinary Medicine, Shandong Agricultural University, Tai'an, 271018, China.

Jingwen Xue (J)

College of Veterinary Medicine, Shandong Agricultural University, Tai'an, 271018, China.

Yongxiu Yao (Y)

The Pirbright Institute & UK-China Centre of Excellence On Avian Disease Research, Pirbright, Ash Road, Guildford, GU24 0NF, Surrey, UK.

Defang Zhou (D)

College of Veterinary Medicine, Shandong Agricultural University, Tai'an, 271018, China. zhoudefang@126.com.

Ziqiang Cheng (Z)

College of Veterinary Medicine, Shandong Agricultural University, Tai'an, 271018, China. czqsd@126.com.

Articles similaires

Robotic Surgical Procedures Animals Humans Telemedicine Models, Animal

Odour generalisation and detection dog training.

Lyn Caldicott, Thomas W Pike, Helen E Zulch et al.
1.00
Animals Odorants Dogs Generalization, Psychological Smell
Animals TOR Serine-Threonine Kinases Colorectal Neoplasms Colitis Mice
Animals Tail Swine Behavior, Animal Animal Husbandry

Classifications MeSH